TF and glioblastoma: To confirm that the reprogrammed TF network during MT is indeed clinically significant, we performed immunohistochemical (IHC) staining in a glioblastoma tumour microarray with 40 clinical WHO grade IV glioblastoma specimen serial paraffin‐embedded sections.23